BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 118 filers reported holding BIOXCEL THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,760 | -64.3% | 1,015 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $18,940 | -32.4% | 1,015 | -22.2% | 0.00% | 0.0% |
| Q4 2022 | $28,031 | +81.7% | 1,305 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $15,425 | -10.5% | 1,305 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $17,226 | -36.9% | 1,305 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $27,288 | -72.5% | 1,305 | -73.3% | 0.00% | 0.0% |
| Q4 2021 | $99,251 | -33.0% | 4,882 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $148,169 | +28.3% | 4,882 | +22.9% | 0.00% | 0.0% |
| Q2 2021 | $115,455 | -21.3% | 3,973 | +16.8% | 0.00% | 0.0% |
| Q1 2021 | $146,787 | -6.6% | 3,401 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $157,126 | +6.5% | 3,401 | 0.0% | 0.00% | -33.3% |
| Q3 2020 | $147,467 | -18.2% | 3,401 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $180,287 | – | 3,401 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 60,000 | $151,800 | 0.16% |
| XTX Topco Ltd | 33,605 | $85,021 | 0.02% |
| Beacon Pointe Advisors, LLC | 301,735 | $763,390 | 0.01% |
| AllSquare Wealth Management LLC | 4,527 | $11,453 | 0.01% |
| Virtus ETF Advisers LLC | 4,646 | $11,754 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 27,553 | $69,709 | 0.01% |
| SeaCrest Wealth Management, LLC | 16,550 | $41,872 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 33,940 | $85,868 | 0.01% |
| Cutler Group LLC / CA | 4,000 | $50 | 0.01% |
| Capital Investment Advisory Services, LLC | 17,991 | $45,517 | 0.00% |